Teddyform Extended-Release Tablet 20/1000 milligrams

Adult dose

This medication is generally administered once daily with dinner, with the 20/1000mg extended-release tablet taken as 1 tablet per day. For patients taking 10/750mg or 10/500mg extended-release tablets, 2 tablets should be taken simultaneously once daily. The initial dose provides Teneligliptin 20mg once daily along with the existing dosage of Metformin. The maximum recommended dosage per day is Teneligliptin 20mg and long-acting Metformin.

This medication is used for the treatment of diabetes and helps lower blood sugar. However, there is a need for caution as very rarely serious side effects such as lactic acidosis can occur. Particularly, it is safer for patients with impaired kidney function, heart disease, or liver dysfunction not to use this medication. The use of this medication should be paused for a certain period before and after examinations using contrast agents, and it should only be resumed after confirming that kidney function is normal post-examination. Pregnant women or women capable of becoming pregnant, patients with severe infections or major trauma should also avoid this medication. When using this medication with other diabetes drugs, symptoms of hypoglycemia may appear, so blood sugar should be checked regularly and symptoms should be closely monitored. If symptoms of hypoglycemia occur, immediate action such as consuming foods containing sugar is necessary. This medication can affect liver and kidney function, so regular blood tests and kidney function tests should be conducted, with extra caution for the elderly. Alcohol consumption may increase the risk of lactic acidosis, so drinking should be avoided during treatment. In addition, this medication can lower vitamin B12 levels, so it is advisable to monitor blood levels regularly. In cases of surgery or significant illness that restrict food intake, this medication should also be temporarily discontinued. If during the course of this medication, sudden abdominal pain, vomiting, breathing difficulties, or weakness occurs, immediate consultation with a physician is necessary. Furthermore, if there are blisters or rashes on the skin, medication should be stopped immediately, and a specialist should be consulted. This medication is not recommended for children as its safety has not been established. Finally, while taking this medication, caution should be exercised for hypoglycemia or lactic acidosis symptoms when performing dangerous tasks such as driving or working at heights.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe hypoglycemia, intestinal obstruction, liver dysfunction, interstitial pneumonia, pseudo-porphyria, acute pancreatitis, lactic acidosis, liver abnormalities (jaundice), sudden and severe headache, seizures, confusion, visual disturbances, paralysis, neurological disorders (cerebral infarction, hepatic coma, sensory disturbances, facial paralysis), severe edema or abnormal urination (marked reduction in urine volume)

Mild side effects

• Hypoglycemia
• constipation
• dizziness
• headache
• weakness
• hunger
• fatigue
• facial swelling
• diarrhea
• indigestion

This medication should be stored in an airtight container that allows for good airflow, and the storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. Storing it this way will help maintain its effectiveness.

Appearance

Pink oval-shaped extended-release film-coated tablets

Package unit

30 tablets/bottle